ArticleEuropean journal of neurology2025

AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls.

Amol K Bhandage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.